非侵襲的出生前検査 (NIPT) 市場 – 2029年までの世界予測

Report Overview

The global non-invasive prenatal testing (NIPT) market is projected to reach USD 14.1 billion by 2029 from USD 7.2 billion in 2024 at a CAGR of 14.5%.

世界の非侵襲的出生前検査（NIPT）市場は、CAGR 14.5%で、2024年の72億米ドルから2029年までに141億米ドルに達すると予測されています。

The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2021 and June 2024. Players in the global non-invasive prenatal testing (NIPT) market have employed various strategies to expand their global footprint and increase their market shares such as partnerships, agreements, divestitures, expansions, and acquisitions.

“The Service segment accounted for the second-largest market share in the non-invasive prenatal testing (NIPT) market.”

By products & service, service segment holds the second largest market share in the non-invasive prenatal testing (NIPT) market due to the growing preference for outsourcing complex diagnostic procedures to specialized service providers. These providers offer advanced technology and expertise, ensuring accurate and timely results, which are crucial for expectant parents making informed decisions about their pregnancies. Additionally, service providers often have the infrastructure to handle high volumes of tests, which can be more cost-effective for healthcare facilities than maintaining in-house capabilities. This outsourcing trend drives the substantial market share held by the service segment in the NIPT market.

“cfDNA in maternal plasma test segment of the non-invasive prenatal testing (NIPT) market is expected to witness the fastest CAGR.”

By method type, the cfDNA in maternal plasma test segment has witnessed the fastest growth rate in the non-invasive prenatal testing (NIPT) market. This is largely due to its high accuracy and safety. Unlike traditional invasive methods such as amniocentesis, cfDNA testing involves a simple blood draw from the mother, minimizing risk to both the mother and the fetus. This non-invasive approach can detect a wide range of genetic conditions early in pregnancy with high sensitivity and specificity, leading to increased adoption by healthcare providers and expectant parents seeking reliable, low-risk prenatal screening options.

“The Microdeletion syndrome segment of the non-invasive prenatal testing (NIPT) market accounted for the second largest market share.”

Based on application type, the microdeletion syndrome segment has accounted for the second largest market share in the Non-invasive Prenatal Testing (NIPT) market primarily due to the increasing awareness and advancements in genetic testing technologies. Microdeletion syndromes, which involve the deletion of small chromosome segments, can lead to significant developmental disorders and health issues in newborns. As a result, expectant parents are increasingly opting for NIPT to detect these conditions early, allowing for better preparedness and management. Moreover, NIPT offers a safe, non-invasive alternative to traditional diagnostic methods, further driving its adoption.

“Diagnostic laboratories segment of the non-invasive prenatal testing (NIPT) market holds the largest market share.”

By end user type, the diagnostic laboratories segment has accounted for the largest market share, in the non-invasive prenatal testing (NIPT) market, due to their advanced technological capabilities and infrastructure, which enable accurate and efficient testing. These laboratories are equipped with cutting-edge equipment and specialized personnel, ensuring high-quality results. Additionally, they often have established relationships with healthcare providers and insurance companies, streamlining the process for patients and physicians. This integration of superior technology, expertise, and streamlined operations makes diagnostic laboratories the preferred choice for NIPT, thereby securing the largest market share in this segment.

“APAC region to have  the third largest market share in the non-invasive prenatal testing (NIPT) market, by region.”

In the APAC region, the non-invasive prenatal testing (NIPT) market has grown significantly. This is mainly because of the region’s rapidly growing population and increasing awareness of prenatal health. With countries like China and India having large and expanding populations, there is a heightened demand for advanced prenatal testing solutions. The growing middle class in these countries is also becoming more health-conscious and willing to invest in high-quality healthcare services, including non-invasive prenatal testing. Additionally, the rising incidence of advanced maternal age and a greater emphasis on early disease detection further drive the demand for NIPT. These factors collectively contribute to APAC’s leading position in the global market for non-invasive prenatal testing.

A breakdown of the primary participants (supply side) for the non-invasive prenatal testing (NIPT) market referred to for this report is provided below:

• By Company Type: Tier 1–35%, Tier 2–25%, and Tier 3–40%
• By Designation: C-level–45%, Director Level–25%, and Others–30%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America-10%, and Middle East & Africa_ 7%

A breakdown of the primary participants (demand side) for the non-invasive prenatal testing (NIPT) market refer to for the report is provided below:

• By End User Type: Diagnostic Laboratory-65%, Hospitals-35%
• By Designation: Laboratories Technicians-55%, Doctor-45%
• By Region: North America–34%, Europe–27%, Asia Pacific–23%, Latin America-9%, and Middle East & Africa-7%

Key Market Players:

The prominent players in the non-invasive prenatal testing (NIPT) market include Illumina, Inc. (US), Natera, Inc. (US), Laboratory Corporation of America Holdings (US), Eurofins Sceintific (France), F. Hoffmann-La Roche AG (Switzerland). Revvity, Inc. (US), Thermo Fisher Scientific Inc (US), Agilent Technologies (US), GE Healthcare Technologies Inc. (US), Quest Diagnostics Incorporated (US), Sonic Healthcare Limited (Australia), Centogene N.V. (Germany), Qiagen N.V. (Germany), Pathwest Laboratory Medicine WA (Australia), Myriad Genetics Inc. (US), BGI Genomics Co., Ltd. (China), Oxford Nanopore Technologies Plc. (UK), Medgenome (India), Neuberg Diagnostics (India), Anngroad Gene Technology (China), Next Biosciences (South Africa), Lilac Insights (India), Invitae Corporation (US), Baylor Genetics (US), Raven (US).

Research Coverage:

The market analysis examines the non-invasive prenatal testing (NIPT) market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product and service, method type, application type, end user type and geography. The study also includes a detailed competitive analysis of the market’s top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the non-invasive prenatal testing (NIPT) market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.

This report provides insights into the following pointers:

Analysis of key Drivers: Drivers (High risk of chromosomal abnormalities with increasing maternal age, Growing preference for non-invasive techniques over invasive methods, Improving reimbursement scenario for NIPT, Programs focusing on increasing awareness of NIPT), Restrains (High cost of procedures, Lack of insurance coverage), Opportunities (Untapped emerging markets, Technological Advancements), Challenges (Reliability of test results especially in obese women, Lack of skilled professionals) influencing the growth of the non-invasive prenatal testing (NIPT) market.

• Market Penetration: Comprehensive information on the product portfolios of the leading companies in the non-invasive prenatal testing (NIPT) market. The report breaks down the market by product and service type, method types, application types, end user types and region.
• Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the non-invasive prenatal testing (NIPT) market.
• Market Development: Comprehensive data on attractive rising markets broken down by product and service type, method types, application types, end user types and region.
• Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the non-invasive prenatal testing (NIPT) market.
• Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main non-invasive prenatal testing (NIPT) products manufacturers.

Table of Contents

1               INTRODUCTION        30

1.1            STUDY OBJECTIVES 30

1.2            MARKET DEFINITION                30

1.3            MARKET SCOPE      31

1.3.1        MARKETS COVERED                 31

1.3.2        INCLUSIONS & EXCLUSIONS   32

1.3.3        YEARS CONSIDERED                32

1.3.4        CURRENCY CONSIDERED        33

1.4            STAKEHOLDERS      33

1.5            SUMMARY OF CHANGES         34

2               RESEARCH METHODOLOGY    35

2.1            RESEARCH DATA     35

2.1.1        SECONDARY DATA   36

2.1.1.1     Key data from secondary sources           37

2.1.2        PRIMARY DATA         38

2.1.2.1     Key data from primary sources                39

2.1.2.2     Key industry insights                39

2.2            MARKET SIZE ESTIMATION      41

2.3            MARKET BREAKDOWN & DATA TRIANGULATION    46

2.4            MARKET SHARE ESTIMATION 46

2.5            ASSUMPTIONS        47

2.6            RISK ASSESSMENT 47

2.7            RESEARCH LIMITATIONS         47

3               EXECUTIVE SUMMARY             48

4               PREMIUM INSIGHTS                 54

4.1            NON-INVASIVE PRENATAL TESTING MARKET OVERVIEW        54

4.2            EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION               55

4.3            GEOGRAPHIC MIX: NON-INVASIVE PRENATAL TESTING MARKET,

2024–2029 (USD MILLION)   56

4.4            NON-INVASIVE PRENATAL TESTING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2024 VS. 2029      56

5               MARKET OVERVIEW 57

5.1            INTRODUCTION        57

5.2            MARKET DYNAMICS                 57

5.2.1        DRIVERS  58

5.2.1.1     High risk of chromosomal abnormalities with increasing

maternal age            58

5.2.1.2     Growing preference for noninvasive techniques over invasive methods                59

5.2.1.3     Improving reimbursement scenario        59

5.2.1.4     Initiatives to spread awareness               60

5.2.2        RESTRAINTS             60

5.2.2.1     High cost of procedures          60

5.2.2.2     Lack of insurance coverage    61

5.2.3        OPPORTUNITIES      61

5.2.3.1     Untapped emerging markets  61

5.2.3.2     Technological advancements 62

5.2.4        CHALLENGES           62

5.2.4.1     Reliability of test results          62

5.2.4.2     Lack of skilled professionals  62

5.3            INDUSTRY TRENDS 63

5.3.1        DETECTION BEYOND TRISOMIES             63

5.3.2        EARLIER GESTATIONAL AGE TESTING     64

5.3.3        INTEGRATION WITH NGS         64

5.4            TECHNOLOGY ANALYSIS          64

5.4.1        KEY TECHNOLOGIES                64

5.4.1.1     Cell-free DNA analysis              64

5.4.1.2     NGS          65

5.4.1.3     Digital PCR               65

5.4.2        COMPLEMENTARY TECHNOLOGIES        66

5.4.2.1     Microfluidics            66

5.4.2.2     Nanotechnology      66

5.4.2.3     Epigenetics analysis                 67

5.4.3        ADJACENT TECHNOLOGIES     67

5.4.3.1     Ultrasound imaging 67

5.4.3.2     Genome editing (CRISPR/Cas9)              67

5.4.3.3     Liquid biopsy            68

5.5            VALUE CHAIN ANALYSIS           68

5.6            ECOSYSTEM ANALYSIS            69

5.7            SUPPLY CHAIN ANALYSIS        71

5.8            PORTER’S FIVE FORCE ANALYSIS            72

5.8.1        THREAT OF NEW ENTRANTS   73

5.8.2        THREAT OF SUBSTITUTES        74

5.8.3        BARGAINING POWER OF SUPPLIERS      74

5.8.4        BARGAINING POWER OF BUYERS            74

5.8.5        INTENSITY OF COMPETITIVE RIVALRY     74

5.9            KEY STAKEHOLDERS AND BUYING CRITERIA          75

5.9.1        KEY STAKEHOLDERS IN BUYING PROCESS             75

5.9.2        BUYING CRITERIA    76

5.10         REGULATORY LANDSCAPE      76

5.10.1      REGULATORY ANALYSIS          76

5.10.2      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 78

5.11         PATENT ANALYSIS   80

5.11.1      PATENT PUBLICATION TRENDS                80

5.11.2      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS      81

5.12         TRADE ANALYSIS     84

5.12.1      TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS        84

5.13         PRICING ANALYSIS  84

5.13.1      AVERAGE SELLING PRICE TREND, BY PRODUCT     85

5.13.2      AVERAGE SELLING PRICE TREND, BY REGION        85

5.14         REIMBURSEMENT ANALYSIS  86

5.15         KEY CONFERENCES AND EVENTS, 2024–2025    87

5.16         UNMET NEEDS/END-USER EXPECTATIONS             88

5.17         CASE STUDIES         89

5.17.1      EVALUATION OF NIFTY TEST IN DETECTING FETAL CHROMOSOMAL ABNORMALITIES IN ASIAN POPULATIONS               89

5.17.2      CLINICAL UTILITY OF HARMONY PRENATAL TEST IN A COHORT OF PREGNANT WOMEN                  89

5.17.3      ASSESSMENT OF PANORAMA TEST IN DETECTING FETAL GENETIC CONDITIONS 90

5.18         ADJACENT MARKET ANALYSIS                 90

5.19         INVESTMENT & FUNDING SCENARIO      91

5.20         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           91

5.21         IMPACT OF ARTIFICIAL INTELLIGENCE ON NON-INVASIVE PRENATAL TESTING MARKET                  92

6               NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE 93

6.1            INTRODUCTION        94

6.2            PRODUCTS               95

6.2.1        CONSUMABLES       98

6.2.1.1     Assay kits & reagents               100

6.2.1.1.1 Frequent use of reagents and assay kits to drive market       100

6.2.1.2     Disposables             102

6.2.1.2.1 Need for contamination-free workflow to boost demand for disposables               102

6.2.2        INSTRUMENTS         104

6.2.2.1     Ultrasound devices 107

6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety to drive market                  107

6.2.2.2     NGS systems            109

6.2.2.2.1 Rising use of NGS in NIPT to drive market               109

6.2.2.3     PCR instruments     111

6.2.2.3.1 Increasing research in prenatal genetic testing to boost market growth                 111

6.2.2.4     Microarrays              113

6.2.2.4.1 Flexibility of chips and short processing times to support usage            113

6.2.2.5     Other instruments   115

6.3            SERVICES                 117

6.3.1        NORTH AMERICA TO REGISTER HIGHEST DEMAND FOR TESTING SERVICES         117

7               NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD    120

7.1            INTRODUCTION        121

7.2            ULTRASOUND DETECTION       121

7.2.1        ULTRASOUND DETECTION TO DOMINATE NIPT MARKET        121

7.3            BIOCHEMICAL SCREENING TESTS           124

7.3.1        HIGH INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH               124

7.4            CFDNA IN MATERNAL PLASMA TESTS     126

7.4.1        CFDNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER HIGHEST CAGR    126

8               NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION              129

8.1            INTRODUCTION        130

8.2            TRISOMY 131

8.2.1        TRISOMY TO HOLD LARGEST SHARE OF APPLICATIONS MARKET AND SHOW HIGHEST GROWTH 131

8.3            MICRODELETION SYNDROME 133

8.3.1        INCREASING AWARENESS TO SUPPORT DEMAND FOR TESTING            133

8.4            OTHER APPLICATIONS             135

9               NON-INVASIVE PRENATAL TESTING MARKET, BY END USER  138

9.1            INTRODUCTION        139

9.2            DIAGNOSTIC LABORATORIES  139

9.2.1        RISING RESEARCH INTENSITY TO DRIVE USAGE OF NIPT PRODUCTS IN DIAGNOSTIC LABS                  139

9.3            HOSPITALS               141

9.3.1        RISING INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO PROPEL MARKET 141

10             NON-INVASIVE PRENATAL TESTING MARKET, BY REGION      144

10.1         INTRODUCTION        145

10.2         NORTH AMERICA     146

10.2.1      NORTH AMERICA: MACROECONOMIC OUTLOOK    147

10.2.2      US             154

10.2.2.1  High incidence of chromosomal syndromes to drive demand                 154

10.2.3      CANADA   159

10.2.3.1  Unfavorable reimbursement scenario for NIPT to challenge market growth           159

10.3         EUROPE   164

10.3.1      EUROPE: MACROECONOMIC OUTLOOK  165

10.3.2      UK            171

10.3.2.1  High incidence of genetic abnormalities to increase demand for prenatal testing 171

10.3.3      GERMANY                 176

10.3.3.1  Strong R&D and increasing healthcare spending to drive market          176

10.3.4      FRANCE   182

10.3.4.1  Favorable insurance coverage for prenatal testing to increase adoption of NIPT  182

10.3.5      ITALY        187

10.3.5.1  Favorable funding scenario for genomics to drive market     187

10.3.6      SPAIN       192

10.3.6.1  Rising funding and expanding research infrastructure to propel market growth   192

10.3.7      REST OF EUROPE    198

10.4         ASIA PACIFIC            203

10.4.1      ASIA PACIFIC: MACROECONOMIC OUTLOOK           203

10.4.2      JAPAN      210

10.4.2.1  Rising maternal age to propel incidence of chromosomal disorders     210

10.4.3      CHINA      215

10.4.3.1  China to register highest growth in Asia Pacific market          215

10.4.4      INDIA        221

10.4.4.1  Rising disposable income and demand for better health to support market growth                  221

10.4.5      AUSTRALIA                226

10.4.5.1  Strong research ecosystem for NIPT to drive market              226

10.4.6      SOUTH KOREA         231

10.4.6.1  Increasing scope for genomic research to support market growth         231

10.4.7      REST OF ASIA PACIFIC              237

10.5         LATIN AMERICA        242

10.5.1      LATIN AMERICA: MACROECONOMIC OUTLOOK       242

10.5.2      BRAZIL     248

10.5.2.1  Rising focus on clinical genomics to drive demand for NIPT  248

10.5.3      MEXICO   253

10.5.3.1  High incidence of Down syndrome to propel demand             253

10.5.4      REST OF LATIN AMERICA         258

10.6         MIDDLE EAST & AFRICA           263

10.6.1      MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK          263

10.6.2      GCC COUNTRIES      269

10.6.2.1  Launch of genomic initiatives to drive market        269

10.6.3      REST OF MIDDLE EAST & AFRICA            274

11             COMPETITIVE LANDSCAPE      280

11.1         OVERVIEW                280

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN                280

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NON-INVASIVE PRENATAL TESTING MARKET  281

11.3         REVENUE ANALYSIS                 282

11.4         MARKET SHARE ANALYSIS      282

11.5         R&D EXPENDITURE OF KEY PLAYERS     285

11.6         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023            285

11.6.1      STARS      285

11.6.2      EMERGING LEADERS               286

11.6.3      PERVASIVE PLAYERS                286

11.6.4      PARTICIPANTS         286

11.6.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023          287

11.6.5.1  Company footprint  287

11.6.5.2  Product & service footprint     288

11.6.5.3  Method footprint     289

11.6.5.4  Application footprint                 290

11.6.5.5  End-user footprint   291

11.6.5.6  Region footprint       292

11.7         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023     293

11.7.1      PROGRESSIVE COMPANIES    293

11.7.2      DYNAMIC COMPANIES             293

11.7.3      STARTING BLOCKS 293

11.7.4      RESPONSIVE COMPANIES       293

11.7.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023     295

11.8         VALUATION & FINANCIAL METRICS          296

11.9         BRAND/PRODUCT COMPARATIVE ANALYSIS           297

11.10       COMPETITIVE SCENARIO         298

11.10.1   PRODUCT & SERVICE LAUNCHES            298

11.10.2   DEALS      299

11.10.3   EXPANSIONS            300

11.10.4   OTHER DEVELOPMENTS          300

12             COMPANY PROFILES                301

12.1         KEY PLAYERS           301

12.1.1      ILLUMINA, INC.         301

12.1.1.1  Business overview  301

12.1.1.2  Products & services offered   302

12.1.1.3  Recent developments              304

12.1.1.3.1                Product launches & approvals                 304

12.1.1.3.2                Expansions               305

12.1.1.3.3                Other developments                305

12.1.1.4  MnM view                 306

12.1.1.4.1                Key strengths           306

12.1.1.4.2                Strategic choices     306

12.1.1.4.3                Weaknesses & competitive threats        306

12.1.2      NATERA, INC.            307

12.1.2.1  Business overview  307

12.1.2.2  Products & services offered   308

12.1.2.3  Recent developments              308

12.1.2.3.1                Product & service launches and approvals             308

12.1.2.3.2                Deals       308

12.1.2.4  MnM view                 309

12.1.2.4.1                Key strengths           309

12.1.2.4.2                Strategic choices     309

12.1.2.4.3                Weaknesses & competitive threats        309

12.1.3      LABORATORY CORPORATION OF AMERICA HOLDINGS           310

12.1.3.1  Business overview  310

12.1.3.2  Products & services offered   311

12.1.3.3  Recent developments              312

12.1.3.3.1                Deals       312

12.1.3.4  MnM view                 313

12.1.3.4.1                Key strengths           313

12.1.3.4.2                Strategic choices     313

12.1.3.4.3                Weaknesses & competitive threats        313

12.1.4      EUROFINS SCIENTIFIC              314

12.1.4.1  Business overview  314

12.1.4.2  Products & services offered   316

12.1.4.3  Recent developments              316

12.1.4.3.1                Service launches     316

12.1.4.3.2                Deals       316

12.1.4.4  MnM view                 317

12.1.4.4.1                Key strengths           317

12.1.4.4.2                Strategic choices     317

12.1.4.4.3                Weaknesses & competitive threats        317

12.1.5      F. HOFFMANN-LA ROCHE AG   318

12.1.5.1  Business overview  318

12.1.5.2  Products & services offered   319

12.1.5.3  Recent developments              320

12.1.5.3.1                Product launches    320

12.1.5.3.2                Deals       321

12.1.5.4  MnM view                 321

12.1.5.4.1                Key strengths           321

12.1.5.4.2                Strategic choices     321

12.1.5.4.3                Weaknesses & competitive threats        321

12.1.6      REVVITY, INC.           322

12.1.6.1  Business overview  322

12.1.6.2  Products & services offered   324

12.1.6.3  Recent developments              325

12.1.6.3.1                Product launches    325

12.1.6.3.2                Deals       325

12.1.7      THERMO FISHER SCIENTIFIC INC.            326

12.1.7.1  Business overview  326

12.1.7.2  Products & services offered   327

12.1.7.3  Recent developments              328

12.1.7.3.1                Deals       328

12.1.8      AGILENT TECHNOLOGIES        329

12.1.8.1  Business overview  329

12.1.8.2  Products & services offered   331

12.1.8.3  Recent developments              331

12.1.8.3.1                Deals       331

12.1.9      GE HEALTHCARE TECHNOLOGIES INC.   332

12.1.9.1  Business overview  332

12.1.9.2  Products & services offered   333

12.1.9.3  Recent developments              334

12.1.9.3.1                Product & service launches and approvals             334

12.1.9.3.2                Expansions               334

12.1.10   QUEST DIAGNOSTICS INCORPORATED   335

12.1.10.1                 Business overview  335

12.1.10.2                 Products & services offered   336

12.1.10.3                 Recent developments              336

12.1.10.3.1              Product launches    336

12.1.10.3.2              Deals       337

12.1.11   SONIC HEALTHCARE LIMITED 338

12.1.11.1                 Business overview  338

12.1.11.2                 Products & services offered   339

12.1.11.3                 Recent developments              340

12.1.11.3.1              Deals       340

12.1.11.3.2              Expansions               340

12.1.12   CENTOGENE N.V.     341

12.1.12.1                 Business overview  341

12.1.12.2                 Products & services offered   342

12.1.12.3                 Recent developments              343

12.1.12.3.1              Product launches    343

12.1.12.3.2              Deals       343

12.1.12.3.3              Other developments                343

12.1.13   QIAGEN N.V.             344

12.1.13.1                 Business overview  344

12.1.13.2                 Products & services offered   346

12.1.13.3                 Recent developments              346

12.1.13.3.1              Product launches    346

12.1.13.3.2              Deals       347

12.1.13.3.3              Expansions               347

12.1.14   PATHWEST LABORATORY MEDICINE WA 348

12.1.14.1                 Business overview  348

12.1.14.2                 Products & services offered   349

12.1.15   MYRIAD GENETICS, INC.          350

12.1.15.1                 Business overview  350

12.1.15.2                 Products & services offered   351

12.2         OTHER PLAYERS      352

12.2.1      BGI GENOMICS CO., LTD.         352

12.2.2      OXFORD NANOPORE TECHNOLOGIES PLC              353

12.2.3      MEDGENOME          354

12.2.4      NEUBERG DIAGNOSTICS         355

12.2.5      ANNOROAD GENE TECHNOLOGY             356

12.2.6      NEXT BIOSCIENCES 357

12.2.7      LILAC INSIGHTS       357

12.2.8      INVITAE CORPORATION            358

12.2.9      BAYLOR GENETICS  359

12.2.10   RAVGEN   360

13             APPENDIX                 361

13.1         DISCUSSION GUIDE 361

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                367

13.3         CUSTOMIZATION OPTIONS      369

13.4         RELATED REPORTS 369

13.5         AUTHOR DETAILS     370

LIST OF TABLES

TABLE 1   STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 33

TABLE 2   RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE            58

TABLE 3   INCIDENCE RATE OF TRISOMY                 59

TABLE 4   COMPARISON OF NONINVASIVE AND INVASIVE PRENATAL TESTING      59

TABLE 5   NIPT REIMBURSEMENT SCENARIO, BY COUNTRY  60

TABLE 6   PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)   61

TABLE 7   NIPT MARKET: ECOSYSTEM ANALYSIS   70

TABLE 8   NIPT MARKET: PORTER’S FIVE FORCES ANALYSIS 72

TABLE 9   INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS         75

TABLE 10 KEY BUYING CRITERIA FOR NIPT PRODUCTS          76

TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 78

TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS                 78

TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 79

TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 79

TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 80

TABLE 16 LIST OF PATENTS IN NIPT MARKET, 2014–2024   82

TABLE 17 IMPORT AND EXPORT DATA FOR NEXT-GENERATION SEQUENCING PRODUCTS,

BY COUNTRY            84

TABLE 18 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY TYPE             85

TABLE 19 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY REGION        85

TABLE 20 NIPT MARKET: LIST OF KEY CONFERENCES AND EVENTS DURING 2024–2025  87

TABLE 21 NIPT MARKET: UNMET NEEDS                 88

TABLE 22 NIPT MARKET: END-USER EXPECTATIONS               88

TABLE 23 NIPT MARKET: IMPACT AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE             92

TABLE 24 NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)  94

TABLE 25 NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)  94

TABLE 26 NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)          95

TABLE 27 NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)          95

TABLE 28 NIPT PRODUCTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)  96

TABLE 29 NIPT PRODUCTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)  97

TABLE 30 NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)  98

TABLE 31 NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)  98

TABLE 32 NIPT CONSUMABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)           99

TABLE 33 NIPT CONSUMABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)           100

TABLE 34 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)   101

TABLE 35 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)   102

TABLE 36 DISPOSABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)     103

TABLE 37 DISPOSABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)     104

TABLE 38 NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)   105

TABLE 39 NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)   105

TABLE 40 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)             106

TABLE 41 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)             107

TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)       108

TABLE 43 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)       109

TABLE 44 NGS SYSTEMS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)     110

TABLE 45 NGS SYSTEMS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)     111

TABLE 46 PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)             112

TABLE 47 PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)             113

TABLE 48 MICROARRAYS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)    114

TABLE 49 MICROARRAYS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)    115

TABLE 50 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)                  116

TABLE 51 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)                  117

TABLE 52 NIPT SERVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)    118

TABLE 53 NIPT SERVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)    119

TABLE 54 NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)      121

TABLE 55 NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)      121

TABLE 56 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)  122

TABLE 57 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2024–2029 (USD MILLION)  123

TABLE 58 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY,

2021–2023 (USD MILLION)   125

TABLE 59 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY,

2024–2029 (USD MILLION)   126

TABLE 60 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY,

2021–2023 (USD MILLION)   127

TABLE 61 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY,

2024–2029 (USD MILLION)   128

TABLE 62 NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                130

TABLE 63 NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                130

TABLE 64 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2021–2023 (USD MILLION)              132

TABLE 65 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2024–2029 (USD MILLION)              133

TABLE 66 NIPT MARKET FOR MICRODELETION SYNDROME,

BY COUNTRY, 2021–2023 (USD MILLION)              134

TABLE 67 NIPT MARKET FOR MICRODELETION SYNDROME,

BY COUNTRY, 2024–2029 (USD MILLION)              135

TABLE 68 NIPT MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2021–2023 (USD MILLION)              136

TABLE 69 NIPT MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2024–2029 (USD MILLION)              137

TABLE 70 NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)   139

TABLE 71 NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)   139

TABLE 72 NIPT MARKET FOR DIAGNOSTIC LABORATORIES,

BY COUNTRY, 2021–2023 (USD MILLION)              140

TABLE 73 NIPT MARKET FOR DIAGNOSTIC LABORATORIES,

BY COUNTRY, 2024–2029 (USD MILLION)              141

TABLE 74 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2021–2023 (USD MILLION)           142

TABLE 75 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2029 (USD MILLION)           143

TABLE 76 NIPT MARKET, BY REGION, 2021–2023 (USD MILLION)        146

TABLE 77 NIPT MARKET, BY REGION, 2024–2029 (USD MILLION)        146

TABLE 78 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)        148

TABLE 79 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)        149

TABLE 80 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   149

TABLE 81 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   149

TABLE 82 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  150

TABLE 83 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  150

TABLE 84 NORTH AMERICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    150

TABLE 85 NORTH AMERICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    151

TABLE 86 NORTH AMERICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    151

TABLE 87 NORTH AMERICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    151

TABLE 88 NORTH AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)         152

TABLE 89 NORTH AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)         152

TABLE 90 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)  152

TABLE 91 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)  153

TABLE 92 NORTH AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)      153

TABLE 93 NORTH AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)      153

TABLE 94 US: KEY MACROINDICATORS  154

TABLE 95 US: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)             154

TABLE 96 US: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)             155

TABLE 97 US: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)   155

TABLE 98 US: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)   155

TABLE 99 US: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)            156

TABLE 100               US: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  156

TABLE 101               US: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  156

TABLE 102               US: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  157

TABLE 103               US: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                 157

TABLE 104               US: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                 157

TABLE 105               US: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)         158

TABLE 106               US: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)         158

TABLE 107               US: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)              158

TABLE 108               US: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)              159

TABLE 109               CANADA: KEY MACROINDICATORS          159

TABLE 110               CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  160

TABLE 111               CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  160

TABLE 112               CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  160

TABLE 113               CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  161

TABLE 114               CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  161

TABLE 115               CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  161

TABLE 116               CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  162

TABLE 117               CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  162

TABLE 118               CANADA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)       162

TABLE 119               CANADA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)       163

TABLE 120               CANADA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  163

TABLE 121               CANADA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  163

TABLE 122               CANADA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)    164

TABLE 123               CANADA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)    164

TABLE 124               EUROPE: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)      165

TABLE 125               EUROPE: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)      166

TABLE 126               EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  166

TABLE 127               EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  166

TABLE 128               EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  167

TABLE 129               EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  167

TABLE 130               EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  167

TABLE 131               EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  168

TABLE 132               EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  168

TABLE 133               EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  168

TABLE 134               EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)       169

TABLE 135               EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)       169

TABLE 136               EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  169

TABLE 137               EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  170

TABLE 138               EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)    170

TABLE 139               EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)    170

TABLE 140               UK: KEY MACROINDICATORS  171

TABLE 141               UK: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  171

TABLE 142               UK: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  172

TABLE 143               UK: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)   172

TABLE 144               UK: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)   172

TABLE 145               UK: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  173

TABLE 146               UK: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  173

TABLE 147               UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  173

TABLE 148               UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  174

TABLE 149               UK: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                174

TABLE 150               UK: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                174

TABLE 151               UK: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)         175

TABLE 152               UK: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)         175

TABLE 153               UK: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)              175

TABLE 154               UK: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)              176

TABLE 155               GERMANY: KEY MACROINDICATORS      177

TABLE 156               GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  177

TABLE 157               GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  177

TABLE 158               GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  178

TABLE 159               GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  178

TABLE 160               GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 178

TABLE 161               GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 179

TABLE 162               GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  179

TABLE 163               GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  179

TABLE 164               GERMANY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)   180

TABLE 165               GERMANY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)   180

TABLE 166               GERMANY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  180

TABLE 167               GERMANY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  181

TABLE 168               GERMANY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 181

TABLE 169               GERMANY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 181

TABLE 170               FRANCE: KEY MACROINDICATORS          182

TABLE 171               FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  182

TABLE 172               FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  183

TABLE 173               FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  183

TABLE 174               FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  183

TABLE 175               FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  184

TABLE 176               FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  184

TABLE 177               FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  184

TABLE 178               FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  185

TABLE 179               FRANCE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)       185

TABLE 180               FRANCE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)       185

TABLE 181               FRANCE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  186

TABLE 182               FRANCE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  186

TABLE 183               FRANCE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)    186

TABLE 184               FRANCE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)    187

TABLE 185               ITALY: KEY MACROINDICATORS               187

TABLE 186               ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  188

TABLE 187               ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  188

TABLE 188               ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  188

TABLE 189               ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  189

TABLE 190               ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  189

TABLE 191               ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  189

TABLE 192               ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  190

TABLE 193               ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  190

TABLE 194               ITALY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)            190

TABLE 195               ITALY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)            191

TABLE 196               ITALY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)     191

TABLE 197               ITALY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)     191

TABLE 198               ITALY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)         192

TABLE 199               ITALY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)         192

TABLE 200               SPAIN: KEY MACROINDICATORS              193

TABLE 201               SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  193

TABLE 202               SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  193

TABLE 203               SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  194

TABLE 204               SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  194

TABLE 205               SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  194

TABLE 206               SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  195

TABLE 207               SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  195

TABLE 208               SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  195

TABLE 209               SPAIN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)           196

TABLE 210               SPAIN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)           196

TABLE 211               SPAIN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)   196

TABLE 212               SPAIN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)   197

TABLE 213               SPAIN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)        197

TABLE 214               SPAIN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)        197

TABLE 215               REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   198

TABLE 216               REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   198

TABLE 217               REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 199

TABLE 218               REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 199

TABLE 219               REST OF EUROPE: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    199

TABLE 220               REST OF EUROPE: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    200

TABLE 221               REST OF EUROPE: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    200

TABLE 222               REST OF EUROPE: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    200

TABLE 223               REST OF EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                  201

TABLE 224               REST OF EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                  201

TABLE 225               REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  201

TABLE 226               REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  202

TABLE 227               REST OF EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)                  202

TABLE 228               REST OF EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)                  202

TABLE 229               ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)                  205

TABLE 230               ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)                  205

TABLE 231               ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 205

TABLE 232               ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 206

TABLE 233               ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  206

TABLE 234               ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  206

TABLE 235               ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 207

TABLE 236               ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 207

TABLE 237               ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 207

TABLE 238               ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 208

TABLE 239               ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                  208

TABLE 240               ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                  208

TABLE 241               ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  209

TABLE 242               ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  209

TABLE 243               ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)                  209

TABLE 244               ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)                  210

TABLE 245               JAPAN: KEY MACROINDICATORS             210

TABLE 246               JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  211

TABLE 247               JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  211

TABLE 248               JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  211

TABLE 249               JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  212

TABLE 250               JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  212

TABLE 251               JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  212

TABLE 252               JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  213

TABLE 253               JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  213

TABLE 254               JAPAN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)          213

TABLE 255               JAPAN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)          214

TABLE 256               JAPAN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)   214

TABLE 257               JAPAN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)   214

TABLE 258               JAPAN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)        215

TABLE 259               JAPAN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)        215

TABLE 260               CHINA: KEY MACROINDICATORS             216

TABLE 261               CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  216

TABLE 262               CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  216

TABLE 263               CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  217

TABLE 264               CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  217

TABLE 265               CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  217

TABLE 266               CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  218

TABLE 267               CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  218

TABLE 268               CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  218

TABLE 269               CHINA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)          219

TABLE 270               CHINA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)          219

TABLE 271               CHINA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)   219

TABLE 272               CHINA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)   220

TABLE 273               CHINA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)        220

TABLE 274               CHINA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)        220

TABLE 275               INDIA: KEY MACROINDICATORS               221

TABLE 276               INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  221

TABLE 277               INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  222

TABLE 278               INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  222

TABLE 279               INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  222

TABLE 280               INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  223

TABLE 281               INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  223

TABLE 282               INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  223

TABLE 283               INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  224

TABLE 284               INDIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)            224

TABLE 285               INDIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)            224

TABLE 286               INDIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)    225

TABLE 287               INDIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)    225

TABLE 288               INDIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)         225

TABLE 289               INDIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)         226

TABLE 290               AUSTRALIA: KEY MACROINDICATORS     226

TABLE 291               AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 227

TABLE 292               AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 227

TABLE 293               AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  227

TABLE 294               AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  228

TABLE 295               AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 228

TABLE 296               AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 228

TABLE 297               AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  229

TABLE 298               AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  229

TABLE 299               AUSTRALIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)  229

TABLE 300               AUSTRALIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)  230

TABLE 301               AUSTRALIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  230

TABLE 302               AUSTRALIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  230

TABLE 303               AUSTRALIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)                  231

TABLE 304               AUSTRALIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)                  231

TABLE 305               SOUTH KOREA: KEY MACROINDICATORS                232

TABLE 306               SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   232

TABLE 307               SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   232

TABLE 308               SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  233

TABLE 309               SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  233

TABLE 310               SOUTH KOREA: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    233

TABLE 311               SOUTH KOREA: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    234

TABLE 312               SOUTH KOREA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    234

TABLE 313               SOUTH KOREA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    234

TABLE 314               SOUTH KOREA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                  235

TABLE 315               SOUTH KOREA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                  235

TABLE 316               SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  235

TABLE 317               SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  236

TABLE 318               SOUTH KOREA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)                  236

TABLE 319               SOUTH KOREA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)                  236

TABLE 320               REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   237

TABLE 321               REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   237

TABLE 322               REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE,

2021–2023 (USD MILLION)   238

TABLE 323               REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE,

2024–2029 (USD MILLION)   238

TABLE 324               REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    238

TABLE 325               REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    239

TABLE 326               REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    239

TABLE 327               REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    239

TABLE 328               REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                  240

TABLE 329               REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                  240

TABLE 330               REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION,

2021–2023 (USD MILLION)   240

TABLE 331               REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION,

2024–2029 (USD MILLION)   241

TABLE 332               REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 241

TABLE 333               REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 241

TABLE 334               LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)                  242

TABLE 335               LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)                  243

TABLE 336               LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   243

TABLE 337               LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   243

TABLE 338               LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 244

TABLE 339               LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 244

TABLE 340               LATIN AMERICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    244

TABLE 341               LATIN AMERICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    245

TABLE 342               LATIN AMERICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    245

TABLE 343               LATIN AMERICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    245

TABLE 344               LATIN AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                  246

TABLE 345               LATIN AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                  246

TABLE 346               LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  246

TABLE 347               LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  247

TABLE 348               LATIN AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)                  247

TABLE 349               LATIN AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)                  247

TABLE 350               BRAZIL: KEY MACROINDICATORS            248

TABLE 351               BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  248

TABLE 352               BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  249

TABLE 353               BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  249

TABLE 354               BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  249

TABLE 355               BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  250

TABLE 356               BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  250

TABLE 357               BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  250

TABLE 358               BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  251

TABLE 359               BRAZIL: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)         251

TABLE 360               BRAZIL: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)         251

TABLE 361               BRAZIL: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 252

TABLE 362               BRAZIL: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 252

TABLE 363               BRAZIL: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)      252

TABLE 364               BRAZIL: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)      253

TABLE 365               MEXICO: KEY MACROINDICATORS           253

TABLE 366               MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)                  254

TABLE 367               MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)                  254

TABLE 368               MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  254

TABLE 369               MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  255

TABLE 370               MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)                  255

TABLE 371               MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)                  255

TABLE 372               MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                  256

TABLE 373               MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)                  256

TABLE 374               MEXICO: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)        256

TABLE 375               MEXICO: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)        257

TABLE 376               MEXICO: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 257

TABLE 377               MEXICO: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 257

TABLE 378               MEXICO: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)     258

TABLE 379               MEXICO: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)     258

TABLE 380               REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   258

TABLE 381               REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   259

TABLE 382               REST OF LATIN AMERICA: NIPT PRODUCTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    259

TABLE 383               REST OF LATIN AMERICA: NIPT PRODUCTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    259

TABLE 384               REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    260

TABLE 385               REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    260

TABLE 386               REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    260

TABLE 387               REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    261

TABLE 388               REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 261

TABLE 389               REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 261

TABLE 390               REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION,

2021–2023 (USD MILLION)   262

TABLE 391               REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION,

2024–2029 (USD MILLION)   262

TABLE 392               REST OF LATIN AMERICA: NIPT MARKET, BY END USER,

2021–2023 (USD MILLION)   262

TABLE 393               REST OF LATIN AMERICA: NIPT MARKET, BY END USER,

2024–2029 (USD MILLION)   263

TABLE 394               MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2021–2023 (USD MILLION)                  264

TABLE 395               MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2024–2029 (USD MILLION)                  264

TABLE 396               MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   265

TABLE 397               MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   265

TABLE 398               MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE,

2021–2023 (USD MILLION)   265

TABLE 399               MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE,

2024–2029 (USD MILLION)   266

TABLE 400               MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    266

TABLE 401               MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    266

TABLE 402               MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    267

TABLE 403               MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    267

TABLE 404               MIDDLE EAST & AFRICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 267

TABLE 405               MIDDLE EAST & AFRICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 268

TABLE 406               MIDDLE EAST & AFRICA: NIPT MARKET, BY APPLICATION,

2021–2023 (USD MILLION)   268

TABLE 407               MIDDLE EAST & AFRICA: NIPT MARKET, BY APPLICATION,

2024–2029 (USD MILLION)   268

TABLE 408               MIDDLE EAST & AFRICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 269

TABLE 409               MIDDLE EAST & AFRICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 269

TABLE 410               GCC COUNTRIES: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   270

TABLE 411               GCC COUNTRIES: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   270

TABLE 412               GCC COUNTRIES: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 270

TABLE 413               GCC COUNTRIES: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 271

TABLE 414               GCC COUNTRIES: NIPT CONSUMABLES MARKET, BY TYPE,

2021–2023 (USD MILLION)   271

TABLE 415               GCC COUNTRIES: NIPT CONSUMABLES MARKET, BY TYPE,

2024–2029 (USD MILLION)   271

TABLE 416               GCC COUNTRIES: NIPT INSTRUMENTS MARKET, BY TYPE,

2021–2023 (USD MILLION)   272

TABLE 417               GCC COUNTRIES: NIPT INSTRUMENTS MARKET, BY TYPE,

2024–2029 (USD MILLION)   272

TABLE 418               GCC COUNTRIES: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)                  272

TABLE 419               GCC COUNTRIES: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)                  273

TABLE 420               GCC COUNTRIES: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                  273

TABLE 421               GCC COUNTRIES: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)                  273

TABLE 422               GCC COUNTRIES: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)                  274

TABLE 423               GCC COUNTRIES: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)                  274

TABLE 424               REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,

2021–2023 (USD MILLION)   274

TABLE 425               REST OF MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,

2024–2029 (USD MILLION)   275

TABLE 426               REST OF MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    275

TABLE 427               REST OF MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    275

TABLE 428               REST OF MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2021–2023 (USD MILLION)    276

TABLE 429               REST OF MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET,

BY TYPE, 2024–2029 (USD MILLION)    276

TABLE 430               REST OF MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2021–2023 (USD MILLION)    276

TABLE 431               REST OF MIDDLE EAST & AFRICA: NIPT INSTRUMENTS MARKET,

BY TYPE, 2024–2029 (USD MILLION)    277

TABLE 432               REST OF MIDDLE EAST & AFRICA: NIPT MARKET,

BY METHOD, 2021–2023 (USD MILLION)               277

TABLE 433               REST OF MIDDLE EAST & AFRICA: NIPT MARKET,

BY METHOD, 2024–2029 (USD MILLION)               277

TABLE 434               REST OF MIDDLE EAST & AFRICA: NIPT MARKET,

BY APPLICATION, 2021–2023 (USD MILLION)       278

TABLE 435               REST OF MIDDLE EAST & AFRICA: NIPT MARKET,

BY APPLICATION, 2024–2029 (USD MILLION)       278

TABLE 436               REST OF MIDDLE EAST & AFRICA: NIPT MARKET,

BY END USER, 2021–2023 (USD MILLION)            278

TABLE 437               REST OF MIDDLE EAST & AFRICA: NIPT MARKET,

BY END USER, 2024–2029 (USD MILLION)            279

TABLE 438               OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS       281

TABLE 439               NIPT MARKET: DEGREE OF COMPETITION               283

TABLE 440               NIPT MARKET: PRODUCT & SERVICE FOOTPRINT  288

TABLE 441               NIPT MARKET: METHOD FOOTPRINT       289

TABLE 442               NIPT MARKET: APPLICATION FOOTPRINT                 290

TABLE 443               NIPT MARKET: END-USER FOOTPRINT    291

TABLE 444               NIPT MARKET: REGION FOOTPRINT        292

TABLE 445               NIPT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            295

TABLE 446               NIPT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING STARTUPS/SMES    296

TABLE 447               NIPT MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–JUNE 2024                  298

TABLE 448               NIPT MARKET: DEALS, JANUARY 2021–JUNE 2024                299

TABLE 449               NIPT MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024    300

TABLE 450               NIPT MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024  300

TABLE 451               ILLUMINA: COMPANY OVERVIEW             301

TABLE 452               ILLUMINA: PRODUCTS & SERVICES OFFERED        302

TABLE 453               ILLUMINA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2024                  304

TABLE 454               ILLUMINA: EXPANSIONS, JANUARY 2021–JUNE 2024            305

TABLE 455               ILLUMINA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024          305

TABLE 456               NATERA: COMPANY OVERVIEW                307

TABLE 457               NATERA: PRODUCTS & SERVICES OFFERED           308

TABLE 458               NATERA: PRODUCT & SERVICE LAUNCHES AND APPROVALS,

JANUARY 2021–JUNE 2024   308

TABLE 459               NATERA: DEALS, JANUARY 2021–JUNE 2024        308

TABLE 460               LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW                  310

TABLE 461               LABORATORY CORPORATION OF AMERICA HOLDINGS:

PRODUCTS & SERVICES OFFERED          311

TABLE 462               LABORATORY CORPORATION OF AMERICA HOLDINGS:

DEALS, JANUARY 2021–JUNE 2024       312

TABLE 463               EUROFINS SCIENTIFIC: COMPANY OVERVIEW         314

TABLE 464               EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED    316

TABLE 465               EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021–JUNE 2024                  316

TABLE 466               EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–JUNE 2024 316

TABLE 467               F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW    318

TABLE 468               F. HOFFMANN-LA ROCHE: PRODUCTS & SERVICES OFFERED                 319

TABLE 469               F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024                  320

TABLE 470               F. HOFFMANN-LA ROCHE: DEALS, JANUARY 2021–JUNE 2024              321

TABLE 471               REVVITY: COMPANY OVERVIEW                322

TABLE 472               REVVITY: PRODUCTS & SERVICES OFFERED           324

TABLE 473               REVVITY: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024                 325

TABLE 474               REVVITY: DEALS, JANUARY 2021–JUNE 2024        325

TABLE 475               THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW               326

TABLE 476               THERMO FISHER SCIENTIFIC: PRODUCTS & SERVICES OFFERED          327

TABLE 477               THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021–JUNE 2024       328

TABLE 478               AGILENT TECHNOLOGIES: COMPANY OVERVIEW    329

TABLE 479               AGILENT TECHNOLOGIES: PRODUCTS & SERVICES OFFERED                 331

TABLE 480               AGILENT TECHNOLOGIES: DEALS, JANUARY 2021–JUNE 2024              331

TABLE 481               GE HEALTHCARE: COMPANY OVERVIEW 332

TABLE 482               GE HEALTHCARE: PRODUCTS & SERVICES OFFERED              333

TABLE 483               GE HEALTHCARE: PRODUCT & SERVICE LAUNCHES AND APPROVALS,

JANUARY 2021–JUNE 2024   334

TABLE 484               GE HEALTHCARE: EXPANSIONS, JANUARY 2021–JUNE 2024                 334

TABLE 485               QUEST DIAGNOSTICS: COMPANY OVERVIEW          335

TABLE 486               QUEST DIAGNOSTICS: PRODUCTS & SERVICES OFFERED      336

TABLE 487               QUEST DIAGNOSTICS: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024                  336

TABLE 488               QUEST DIAGNOSTICS: DEALS, JANUARY 2021–JUNE 2024   337

TABLE 489               SONIC HEALTHCARE: COMPANY OVERVIEW            338

TABLE 490               SONIC HEALTHCARE: PRODUCTS & SERVICES OFFERED       339

TABLE 491               SONIC HEALTHCARE: DEALS, JANUARY 2021–JUNE 2024    340

TABLE 492               SONIC HEALTHCARE: EXPANSIONS, JANUARY 2021–JUNE 2024           340

TABLE 493               CENTOGENE: COMPANY OVERVIEW        341

TABLE 494               CENTOGENE: PRODUCTS & SERVICES OFFERED   342

TABLE 495               CENTOGENE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024          343

TABLE 496               CENTOGENE: DEALS, JANUARY 2021–JUNE 2024 343

TABLE 497               CENTOGENE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024     343

TABLE 498               QIAGEN: COMPANY OVERVIEW                344

TABLE 499               QIAGEN: PRODUCTS & SERVICES OFFERED            346

TABLE 500               QIAGEN: PRODUCT & SERVICE LAUNCHES AND APPROVALS,

JANUARY 2021–JUNE 2024   346

TABLE 501               QIAGEN: DEALS, JANUARY 2021–JUNE 2024         347

TABLE 502               QIAGEN: EXPANSIONS, JANUARY 2021–JUNE 2024               347

TABLE 503               PATHWEST LABORATORY MEDICINE: COMPANY OVERVIEW  348

TABLE 504               PATHWEST LABORATORY MEDICINE: PRODUCTS & SERVICES OFFERED                  349

TABLE 505               MYRIAD GENETICS: COMPANY OVERVIEW               350

TABLE 506               MYRIAD GENETICS: PRODUCTS & SERVICES OFFERED          351

LIST OF FIGURES

FIGURE 1 NIPT MARKET SEGMENTATION                31

FIGURE 2 NIPT MARKET: RESEARCH DESIGN         35

FIGURE 3 PRIMARY SOURCES 38

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION   40

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):

BY END USER, DESIGNATION, AND REGION            40

FIGURE 6 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS          41

FIGURE 7 TOP-DOWN APPROACH            42

FIGURE 8 BOTTOM-UP APPROACH          42

FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES       44

FIGURE 10                CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS        45

FIGURE 11                DATA TRIANGULATION METHODOLOGY  46

FIGURE 12                SERVICES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD    48

FIGURE 13                CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET     49

FIGURE 14                DISPOSABLES SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD  49

FIGURE 15                NGS SYSTEMS TO REGISTER HIGHEST GROWTH IN INSTRUMENTS MARKET                  50

FIGURE 16                ULTRASOUND DETECTION SEGMENT TO HOLD LARGEST MARKET SHARE                  50

FIGURE 17                TRISOMY TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD    51

FIGURE 18                DIAGNOSTIC LABORATORIES TO DOMINATE END-USER MARKET           52

FIGURE 19                NORTH AMERICA AND EUROPE ACCOUNTED FOR LARGEST

MARKET SHARES IN 2023      53

FIGURE 20                HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING MATERNAL AGE TO DRIVE ADOPTION        54

FIGURE 21                TRISOMY HELD LARGEST SHARE OF EUROPEAN MARKET IN 2023       55

FIGURE 22                ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD                  56

FIGURE 23                EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING

THE FORECAST PERIOD           56

FIGURE 24                NIPT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                  57

FIGURE 25                INTEGRATION WITH NGS—A LEADING TREND IN NIPT             63

FIGURE 26                VALUE CHAIN ANALYSIS OF NIPT MARKET: R&D AND MANUFACTURING PHASE ADD MAXIMUM VALUE             69

FIGURE 27                NIPT MARKET: ECOSYSTEM    70

FIGURE 28                NIPT MARKET: SUPPLY CHAIN ANALYSIS                 72

FIGURE 29                NIPT MARKET: PORTER’S FIVE FORCES ANALYSIS 73

FIGURE 30                INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS                  75

FIGURE 31                KEY BUYING CRITERIA FOR NIPT PRODUCTS          76

FIGURE 32                GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014─JUNE 2024)                  80

FIGURE 33                TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR NIPT PATENTS (JANUARY 2014─ JUNE 2024)              81

FIGURE 34                TOP APPLICANT COUNTRIES/REGIONS FOR NIPT (JANUARY 2014─ JUNE 2024)      82

FIGURE 35                OVERVIEW OF ADJACENT MARKETS TO NIPT          90

FIGURE 36                NIPT MARKET: INVESTMENT & FUNDING SCENARIO (2019–2023)      91

FIGURE 37                REVENUE SHIFTS IN NIPT MARKET         92

FIGURE 38                NIPT MARKET: GEOGRAPHIC SNAPSHOT                 145

FIGURE 39                NORTH AMERICA: NIPT MARKET SNAPSHOT          148

FIGURE 40                ASIA PACIFIC: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT 204

FIGURE 41                REVENUE ANALYSIS OF TOP PLAYERS IN NIPT MARKET (2021–2023) 282

FIGURE 42                MARKET SHARE ANALYSIS OF KEY PLAYERS IN NIPT MARKET (2023)  283

FIGURE 43                R&D EXPENDITURE OF KEY PLAYERS IN NIPT, 2021–2023  285

FIGURE 44                NIPT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 286

FIGURE 45                NIPT MARKET: COMPANY FOOTPRINT    287

FIGURE 46                NIPT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                  294

FIGURE 47                EV/EBITDA OF KEY PLAYERS  296

FIGURE 48                YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS         297

FIGURE 49                ILLUMINA: COMPANY SNAPSHOT (2023)                302

FIGURE 50                NATERA: COMPANY SNAPSHOT (2023)  307

FIGURE 51                LABORATORY CORPORATION OF AMERICA HOLDINGS:

COMPANY SNAPSHOT (2023) 311

FIGURE 52                EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)            315

FIGURE 53                F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023)       319

FIGURE 54                REVVITY: COMPANY SNAPSHOT (2023) 323

FIGURE 55                THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023) 327

FIGURE 56                AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023)       330

FIGURE 57                GE HEALTHCARE: COMPANY SNAPSHOT (2023)    333

FIGURE 58                QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)              335

FIGURE 59                SONIC HEALTHCARE: COMPANY SNAPSHOT (2023)               339

FIGURE 60                CENTOGENE: COMPANY SNAPSHOT (2023)           342

FIGURE 61                QIAGEN: COMPANY SNAPSHOT (2023)  345

FIGURE 62                PATHWEST LABORATORY MEDICINE: COMPANY SNAPSHOT (2023)     348

FIGURE 63                MYRIAD GENETICS: COMPANY SNAPSHOT (2023) 351

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧